Business Context and Reporting Period
This Form 8-K was filed by SYNNEX CORPORATION on November 24, 2020. The report details an executive compensation agreement for Chris Caldwell, the Chief Executive Officer of Concentrix Corporation, a wholly owned subsidiary of SYNNEX. The agreement pertains to Mr. Caldwell's continued service following the previously announced spin-off of Concentrix from SYNNEX.
Key Financial Metrics
The filing does not provide consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics for SYNNEX Corporation. The financial data contained within is limited to the specific compensation terms outlined in the Offer Letter for Mr. Caldwell:
- Base Salary: $775,000 per year.
- Annual Cash Incentive (FY 2021): Target equal to 2.5 times base salary ($1,937,500).
- FY 2020 Bonus Adjustment: If less than 100% of the SYNNEX target goal is achieved, the bonus is increased by 25% up to a maximum of $1,150,000.
- Equity Awards (Total Fair Market Value): Approximately $11,550,000, consisting of:
- Non-qualified stock option: ~$1,000,000.
- Restricted Stock Grant 1: ~$550,000.
- Restricted Stock Grant 2: $10,000,000.
Material Changes
The primary material change reported is the formalization of executive compensation for the CEO of Concentrix in anticipation of the corporate spin-off. This establishes a new compensation structure for Mr. Caldwell under the Concentrix Board of Directors, distinct from the previous SYNNEX structure, including specific vesting schedules tied to the spin-off effective date.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or general risk factors for SYNNEX Corporation. The document notes that the Offer Letter includes provisions for payments in the event of termination without "cause," though specific amounts are not detailed in the summary text. The equity awards are subject to Mr. Caldwell's continued employment.
Investor Verification Checklist
- Verify the exact effective date of the Concentrix spin-off to determine the vesting start date for the $10,000,000 restricted stock grant.
- Review the full text of Exhibit 10.1 (Offer Letter) for specific definitions of "cause" and termination payment calculations.
- Confirm the status of the Concentrix Compensation Committee's establishment and its authority to set future performance goals.
- Check subsequent filings for the actual trading window opening date for Concentrix to confirm the timing of equity grant issuance.